Article
Trimethylamine N-oxide and risk of inflammatory bowel disease: A Mendelian randomization study
25 Aug 2023
Abstract excerpt
A previous study suggested that inflammatory bowel disease (IBD) patients have low plasma levels of trimethylamine N-oxide (TMAO). In the present study, we examined this hypothesis using Mendelian randomization analysis. We used summary statistics data for single-nucleotide polymorphisms associated with plasma levels of TMAO, and the corresponding data for IBD from a genome-wide association meta-analysis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
